Persistent Bearish Flow in PRME
Prime Medicine (PRME) is currently under heavy short-selling pressure, as evidenced by its inclusion on the latest threshold list. The stock has maintained a short volume ratio of 52% over the past five trading days, indicating that more than half of the daily trading volume is being marked as short. This consistent flow suggests that institutional investors are actively adding to their bearish positions.
Market Sentiment
Despite the high short volume, the stock has shown some price resilience. However, with a short interest of 27.9% and a days-to-cover ratio of 6.3, the setup remains precarious. Traders should monitor the borrow fee and any changes in the short volume ratio, as a sudden spike in either could indicate a shift in the supply-demand balance for shares, potentially leading to increased volatility.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.